v3.25.2
Income Taxes (Tables)
12 Months Ended
Mar. 31, 2024
Income Taxes [Abstract]  
Schedule of Reconciliations of the Differences between the Income Tax Expenses

Reconciliations of the differences between the income tax expenses of the Company and the PRC statutory EIT rate applicable to losses of the consolidated entities are as follows:

 

  

Year ended

March 31, 2022

  

Year ended

March 31, 2023

  

Year ended

March 31, 2024

 
   RMB   RMB   RMB 
                
Loss before income taxes   (134,812)   (106,805)   (69,875)
Income tax computed at respective applicable tax rates   (33,702)   (26,701)   (17,469)
Effect of different tax jurisdiction   2,341    12,323    6,976 
Super deduction for research and development expenses (a)   (1,881)   (456)   (547)
Non-deductible expenses   97    728    115 
Change in valuation allowance   34,716    15,017    11,852 
Total   1,571    911    927 

 

(a)According to the relevant laws and regulations promulgated by the State Administration of Tax of the PRC, from 2013 onwards, enterprises engaging in research and development activities are entitled to claim 200% of their qualified research and development expenses so incurred as tax deductible expenses. The additional deduction of 100% of qualified research and development expenses (the “Super Deduction”) can be directly claimed in the annual EIT filing. For the years end March 31, 2022, 2023 and 2024, the Super Deduction for research and development expenses available to the Company amounted to RMB1.9 million, RMB0.5 million and RMB0.5 million, respectively.
Schedule of Effect of Tax Holiday

The following table sets forth the effect of tax holiday effect on China operations:

 

  

Year ended

March 31, 2022

  

Year ended

March 31, 2023

  

Year ended

March 31, 2024

 
   RMB   RMB   RMB 
                
Tax holiday effect   3,513    1,235    1,882 
Basic and diluted net loss per share effect
   0.05    0.02    0.02 
Schedule of Effective Income Tax Rate and the PRC Statutory Income Tax Rates

Reconciliations between the effective income tax rate and the PRC statutory income tax rates are as follows:

 

  

Year ended

March 31, 2022

  

Year ended

March 31, 2023

  

Year ended

March 31, 2024

 
   RMB   RMB   RMB 
                
PRC statutory income tax rates   25%   25%   25%
Tax holiday effect   3%   (1)%   (3)%
Difference in tax rates of subsidiaries outside PRC   (8)%   (10)%   (5)%
Super deduction for research and development expenses   1%   0%   1%
Non-deductible expenses   0%   1%   0%
Change in valuation allowance   (20)%   (14)%   (17)%
Effective income tax rate   1%   1%   1%
Schedule of Current and Deferred Portions of Income Tax Expenses

The current and deferred portions of income tax expenses included in the consolidated statements of operations and comprehensive loss are as follows:

 

  

Year ended

March 31, 2022

  

Year ended

March 31, 2023

  

Year ended

March 31, 2024

 
   RMB   RMB   RMB 
                
Current income tax expense/(benefit)   (582)   78    (20)
Deferred tax benefit   (989)   (989)   (907)
Income tax credit, net   (1,571)   (911)   (927)
Schedule of Deferred Tax Assets and Tax Liabilities The tax effects of temporary differences that give rise to the deferred tax asset and liabilities balances as of March 31, 2023 and 2024 are as follows:
   As of
March 31,
   As of
March 31,
 
   2023   2024 
   RMB   RMB 
         
Deferred tax assets:        
Net accumulated loss-carry forward   163,526    150,667 
Allowance   238    861 
Contract liabilities   172    60 
Accruals   842    889 
Fair Value Change   1,891    2,778 
Less: Valuation allowance   (166,669)   (155,255)
           
Deferred tax liabilities:          
Recognition of intangible assets arising from asset acquisition and business combination   (4,141)   (3,234)
Schedule of Movement of Valuation Allowance

Movement of valuation allowance is as follows:

 

  

Year ended

March 31, 2022

  

Year ended

March 31, 2023

  

Year ended

March 31, 2024

 
   RMB   RMB   RMB 
             
Beginning balance   149,978    177,247    166,669 
Change of valuation allowance   27,269    15,017    11,852 
Written-off for expiration of net operating losses   
-
    (22,995)   (23,266)
Decrease of valuation allowances related to the disposal of a subsidiary   
-
    (2,600)   
-
 
Ending balance   177,247    166,669    155,255